secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fulgent Genetics, Inc. (FLGT)
CIK:        0001674930
Form:       8-K
Filed at:   2022-05-19T23:59:59+00:00
Accession:  0000950170-22-010338
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Fulgent Genetics holds 2022 annual meeting; all director nominees and proposals approved
--------------------------------------------------------------------------------

- All four director nominees elected: Hsieh 15.9M for, Bolger 10.6M (5.6M withheld), Yen 12.3M, Marsh 12.9M.
- Ratification of Deloitte & Touche as auditor for 2022: 21,789,084 for, 121,792 against.
- Non-binding advisory approval of named executive officer compensation: 15,719,000 for, 405,690 against.
- Advisory vote on frequency of say-on-pay: 16,052,536 for 1 year; board adopted one-year frequency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674930/000095017022010338/0000950170-22-010338-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674930/000095017022010338/flgt-20220518.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-010338

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer